Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03058978 · ClinicalTrials.gov registry record
Assessing Ovarian Function During Prolonged Implant Use
A clinical trial, sponsored by Planned Parenthood of the St. Louis Region and Southwest Missouri.
- Completed
- Registry status
- 117
- Enrollment target
NCT03058978: Completed study, sponsored by Planned Parenthood of the St. Louis Region and Southwest Missouri.
NCT03058978 is a clinical trial that has completed, run by Planned Parenthood of the St. Louis Region and Southwest Missouri. The registered enrollment target is 117 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03058978 has completed, sponsored by Planned Parenthood of the St. Louis Region and Southwest Missouri.
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
Study Summary
The study will evaluate how the ovaries may be functioning while using the the Implanon®/Nexplanon® during the three years beyond the FDA approved duration. Ovarian function will be assessed with weekly serum progesterone levels. Participants will undergo weekly venipuncture for a total of four draws. Participants will be followed for 30 days.
Primary Outcome
Comparisons of serum progesterone levels between BMI (kg/m\^2) categories will be made using ANOVA or Kruskal-WIllis depending on the normality of distribution.
Interventions
- DEVICE Etonogestrel Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2021-12-30 |
What the finished NCT03058978 record still lists
NCT03058978 is an observational study that tracks outcomes without assigning an intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Etonogestrel Implant is the first listed.
NCT03058978 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03058978 about?
NCT03058978 is a clinical study titled "Assessing Ovarian Function During Prolonged Implant Use". The study will evaluate how the ovaries may be functioning while using the the Implanon®/Nexplanon® during the three years beyond the FDA approved duration. Ovarian function will be assessed with weekly serum progesterone levels. Participants will undergo weekly venipuncture for a total of four draw...
What is the current status of trial NCT03058978?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2017-03-01. Estimated completion is 2021-12-30.
What interventions are being tested in trial NCT03058978?
The interventions under investigation include: Etonogestrel Implant (DEVICE).
Who is sponsoring clinical trial NCT03058978?
This trial is sponsored by Planned Parenthood of the St. Louis Region and Southwest Missouri, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI